Minami R, Aoyama N, Honsako Y, Kasuga M, Fujimori T, Maeda S
Second Department of Pathology, Kobe University, Hyogo, Japan.
Dig Dis Sci. 1997 Dec;42(12):2446-52. doi: 10.1023/a:1018839907159.
Recent studies have identified the distinct existence of flat-type colorectal tumors. The low incidence of ras gene mutations in these tumors suggests that their genetic pathways of tumor progression may be different from those of the polypoid type. To elucidate further genetic alterations in flat-type colorectal tumors, codon 201Arg/Gly polymorphism in the DCC (deleted in colorectal carcinoma) gene was analyzed in normal tissue (normal colonic mucosa or peripheral lymphocytes) and in tumor tissue from 191 patients with colorectal tumors (36 patients with flat-type colorectal tumors, 81 patients with polypoid-type colorectal tumors, and 74 patients with advanced carcinomas). For normal controls, 30 samples obtained from patients who had neither colorectal tumors (confirmed by total colonoscopy) nor a family history of colorectal carcinoma were analyzed. DCC gene codon 201Arg/Gly polymorphism was investigated by polymerase chain reaction-based restriction fragment length polymorphism analysis, fluorescence-based dideoxy sequencing, or both. For the flat type, the frequency of codon 201Gly of the DCC gene was 64% and 54% in the normal tissue of patients with adenoma with high-grade dysplasia and submucosal carcinoma, respectively. It was 49%, 52%, and 49% in the normal tissue of patients with polypoid-type adenoma with high-grade dysplasia, submucosal carcinoma, and advanced carcinoma, respectively. In the normal tissue, codon 201Gly of the DCC gene was more frequently observed in patients with flat-type adenoma with low-grade dysplasia (67%) than in those with polypoid-type adenoma with low-grade dysplasia (18%) or in normal controls (17%, P < 0.05, chi2 test). Codon 201Arg/Gly polymorphism in tumor tissues did not differ from that in the corresponding normal tissues, except for 10 cases of carcinoma with loss of heterozygosity (LOH). In carcinomas with LOH, preferential loss of the codon 201Arg allele was noted (9/10 cases). These results suggest that codon 201Gly of the DCC gene is not only associated with flat-type colorectal tumors, but that it may serve as a useful genetic marker for identifying groups at higher risk for colorectal cancer.
最近的研究已经证实了扁平型结直肠肿瘤的独特存在。这些肿瘤中ras基因突变的低发生率表明,其肿瘤进展的遗传途径可能与息肉样类型不同。为了进一步阐明扁平型结直肠肿瘤中的基因改变,对191例结直肠肿瘤患者(36例扁平型结直肠肿瘤患者、81例息肉样结直肠肿瘤患者和74例晚期癌患者)的正常组织(正常结肠黏膜或外周血淋巴细胞)和肿瘤组织中DCC(结直肠癌缺失)基因的201密码子Arg/Gly多态性进行了分析。对于正常对照,分析了从既无结直肠肿瘤(经全结肠镜检查证实)也无结直肠癌家族史的患者中获取的30份样本。通过基于聚合酶链反应的限制性片段长度多态性分析、基于荧光的双脱氧测序或两者相结合的方法研究DCC基因201密码子Arg/Gly多态性。对于扁平型,在高级别异型增生腺瘤和黏膜下癌患者的正常组织中,DCC基因201密码子Gly的频率分别为64%和54%。在高级别异型增生、黏膜下癌和晚期癌的息肉样腺瘤患者的正常组织中,该频率分别为49%、52%和49%。在正常组织中,低级别异型增生的扁平型腺瘤患者(67%)比低级别异型增生的息肉样腺瘤患者(18%)或正常对照(17%,χ2检验,P<0.05)更频繁地观察到DCC基因201密码子Gly。除10例杂合性缺失(LOH)的癌病例外,肿瘤组织中的201密码子Arg/Gly多态性与相应正常组织中的多态性无差异。在伴有LOH的癌中,观察到201密码子Arg等位基因的优先缺失(9/10例)。这些结果表明,DCC基因201密码子Gly不仅与扁平型结直肠肿瘤相关,而且可能作为一种有用的遗传标志物,用于识别结直肠癌高危人群。